Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity.
Mara P SteinkampIrina LagutinaKathryn J BrayerFred A SchultzDanielle BurkeVernon S PankratzSarah F AdamsLaurie G HudsonScott A NessAngela Wandinger-NessPublished in: Cancer research communications (2023)
huPDX models are ideal preclinical models for testing novel therapies. They reflect the genetic heterogeneity of the patient population, enhance human myeloid differentiation, and recruit immune cells to the tumor microenvironment.